After a slow start, cardiac ERAS is gaining traction in some U.S. hospitals. Proponents explain how to overcome resistance. 

Research out of Norway suggests obesity, high blood pressure and diabetes could have a lot to do with CVD’s tendency to present later in life in women than in men.

A study published in JAMA Cardiology Jan. 2 suggests physicians may achieve comparable results when using either radial or femoral access for primary PCI in patients with STEMI.

A hematologist-oncologist from the University of North Carolina has successfully treated a U.S. astronaut’s deep vein thrombosis in the longest telemedicine consultation to date, Forbes reported Jan. 5.

Researchers have developed a new stroke risk score that leverages genetic data to identify people at a particularly high risk of ischemic stroke.

Working long hours was linked to as much as a 70% increased risk of masked hypertension and a 66% greater risk of sustained hypertension in a recent study of 3,500 white-collar employees in Quebec, Canada.

A study published in JAMA Internal Medicine last month found that direct oral anticoagulants were more effective in minimizing AFib patients’ risk of experiencing fracture than warfarin, supporting the theory that the blood thinner might be harmful to bone health.

Research led by a team at the University of Kentucky and funded by the American Heart Association and National Institutes of Health has uncovered a new biomarker for cardiovascular disease: an apolipoprotein/antibody combo.